Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-400,000
Closed -$131M 1019
2025
Q4
$131M Buy
400,000
+200,000
+100% +$63.4M 0.82% 37
2025
Q3
$56.4M Hold
200,000
0.4% 58
2025
Q2
$55.8M Buy
+200,000
New +$56.7M 0.48% 44

Other funds holding AMGN

Marex Group's AMGN Position: Q1 2026 in Review

Marex Group reduced its Amgen (AMGN) stake by 96% in Q1 2026, selling an estimated $17.5M and leaving 2,282 shares worth $803K. The position accounts for 0.01% of the portfolio, ranked #494.

Marex Group first reported a position in AMGN in Q4 2022 and has held it in 9 quarters since. The position peaked at $56.5M in Q3 2025. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Marex Group held 2,282 shares of Amgen worth $803K as of Q1 2026.
  • Marex Group sold 49,080 Amgen shares in Q1 2026, an estimated $17.5M.
  • Amgen made up 0.01% of Marex Group's portfolio in Q1 2026, its #494 holding.
  • Marex Group first reported a position in Amgen in Q4 2022 and has held it in 9 quarters since.
  • Marex Group's Amgen position peaked at $56.5M in Q3 2025.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.